These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37328395)

  • 21. The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases.
    Stekel Z; Sheng Y; Zhang W
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.
    Driscoll JJ; Dechowdhury R
    Target Oncol; 2010 Dec; 5(4):281-9. PubMed ID: 21125340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ubiquitin proteasome system in Caenorhabditis elegans and its regulation.
    Papaevgeniou N; Chondrogianni N
    Redox Biol; 2014; 2():333-47. PubMed ID: 24563851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of ubiquitin proteasome pathway in cancer development.
    Yerlikaya A; Yöntem M
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):298-309. PubMed ID: 23061719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
    Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
    J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in the Discovery of Novel Peptide Inhibitors Targeting 26S Proteasome.
    Gu X; Ma S
    Anticancer Agents Med Chem; 2018; 18(12):1656-1673. PubMed ID: 30101718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research Progress of Ubiquitin Proteasome Inhibitors in Acute Myeloid Leukemia].
    Xiao FN; Zhang MY; Zhou Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):868-875. PubMed ID: 36325785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers.
    Chang SC; Zhang BX; Ding JL
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188679. PubMed ID: 35074437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.
    Aliabadi F; Sohrabi B; Mostafavi E; Pazoki-Toroudi H; Webster TJ
    Open Biol; 2021 Apr; 11(4):200390. PubMed ID: 33906413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors.
    Johnson DE
    Endocr Relat Cancer; 2015 Feb; 22(1):T1-17. PubMed ID: 24659480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
    Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
    Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.
    Allende-Vega N; Saville MK
    Semin Cancer Biol; 2010 Feb; 20(1):29-39. PubMed ID: 19897040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?
    Zhao CX; Zeng CM; Wang K; He QJ; Yang B; Zhou FF; Zhu H
    Acta Pharmacol Sin; 2021 Feb; 42(2):179-188. PubMed ID: 32601365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.
    Wu Q; Zhang L; Xu X; Zhang Y; Shi J; Lin X; Chen W
    J Virol; 2022 Jul; 96(13):e0061122. PubMed ID: 35695579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-26s proteasome system. New therapeutic implications (review).
    Sujashvili R
    Georgian Med News; 2008; (160-161):48-51. PubMed ID: 18711238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay between the Endogenous Opioid System and Proteasome Complex: Beyond Signaling.
    Caputi FF; Rullo L; Stamatakos S; Candeletti S; Romualdi P
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the ubiquitin-proteasome system for cancer therapy.
    Shen M; Schmitt S; Buac D; Dou QP
    Expert Opin Ther Targets; 2013 Sep; 17(9):1091-108. PubMed ID: 23822887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-proteasome pathway and prostate cancer.
    Chen FZ; Zhao XK
    Onkologie; 2013; 36(10):592-6. PubMed ID: 24107915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of deubiquitination in breast cancer.
    Kong L; Jin X
    Gene; 2024 Apr; 902():148175. PubMed ID: 38242375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eat or be eaten: The autophagic plight of inactive 26S proteasomes.
    Marshall RS; Vierstra RD
    Autophagy; 2015; 11(10):1927-8. PubMed ID: 26291247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.